листать назадоглавление

СПИСОК ЛИТЕРАТУРЫ:
  1. Баранова А.В., Янковский Н.К.. Гены супрессоры опухолевого Роста. // Молекулярная Биология, 1998, том 32, № 2, с. 206-218.
  2. Баранова А.В., Иванов Д.В., Макеева Н.В., Коркоран М., Никитин Е.А., Бородина Т.А., Полтараус А.Б., Глинщикова О., Судариков А.Б., Осциер Д., .Янковский Н.К. Геномная организация гена-супрессора опухолевого роста ING1 // Молекуляр. биология, 2000, Т 34, C. 1-7.
  3. Горбунова В.Н., Баранов В.С.: Введение в молекулярную диагностику и генотерапию наследственных заболеваний. СПб. 1997.
  4. Ahuja N., Li Q., Mohan A.L., et al. // Cancer Res. 1998. V. 58. P. 5489-5494.
  5. Beroud C., Soussi T. // Nucleic Acids Res. 1996. V. 24. P. 121-124.
  6. Brehm A. and Kouzaridies T. Retinoblastoma protein mmets chromatin. // Trends in biochemical sciences. 1999. V. 24. P. 142-145.
  7. Buchkovich K.; Duffy L. A. and Harlow E.: The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. // Cell. 1989. V. 58. P. 1097-1105.
  8. Cameron E., Bachman K., Myohanen S., Herman J. et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. // Nature Genetics. 1999. V. 21. P. 103-107.
  9. Chambers A.F., Matrisian L.M. // J. Natl. Cancer Inst. 1997. V. 89. P. 1260-1270.
  10. Chen P. L.; Scully P.; Shew J. Y.; Wang J. Y. J. and Lee W. H.: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.// Cell .1989. V. 58. P. 1193- 1198.
  11. De Stanchina E., McCurrach ME., Zindy F., Shien SY., Ferbeyre G., Samuelson AV., Prives C., Roussel MF., Sherr CJ., Lowe SW.: E1A signaling to p53 involves the p19(ARF) tumor suppressor.// Genes dev. 1998. V. 12. P. 2434-2342.
  12. DeCaprio J. A.; Ludlow J. W.; Lynch D.; Furukawa Y.; Griffin J.; Piwnica-Worms H.; Huang C.M. and Livingston D. M.: The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.// Cell. 1989. V. 58. P. 1085-1095.
  13. Dobrovic A., Simpfendorfer D. // Cancer Res. 1997. V. 57. P. 3347-3350.
  14. Dyson N. The regulation of E2F by pRB-family proteins. // Genes Dev. 1998. V. 12. P. 2245-2262.
  15. Dyson N., Baiman A. Oncogenes and cell proliferation. // Current ooinion in genetics and development. 1999. V. 9. P. 11-14.
  16. Dyson N.; Howley P.M.; Munger K. and Harlow E.: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene prodact.// Science. V. 243. P. 934-937.
  17. Eng C., Mulligan L.M. // Hum. Mutat. 1997. V. 9. P. 97-109.
  18. Feigelson H.S., Ross R.K., Yu M.C., et al. // J. Cell Biochem. 1996. V. 25S. P.15-22.
  19. Feigelson H.S., Shames L.S., Pike M.C., et al. // Cancer Res. 1998. V. 58. P. 585-587.
  20. Fong CT., Dracopoli NC., White PS., Merril PT., Griffith RC., Housman DE., Brodeur GM. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas.// Proc. Nat. Acad. Sci. 1989. V. 86. P. 3753.
  21. Ford D., Easton D.F., Bishop D.T. et al. The Breast Cancer Linkage Consortium. // Lancet. 1994. V. 343. P. 692-695.
  22. Francke U., King F. Sporadic bilateral retinoblastoma and 13q- chromasome deletion.// Medical Pediatr Oncology. 1976. V. 2. P. 379.
  23. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. // Nature, 1998, V. 391, P. 295-8.
  24. Garkavtsev I, Riabowol K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. // Mol. Cell. Biol., 1997, V. 17, P. 2014-9.
  25. Garkavtsev I., Demetrick D., Riabowol K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1) // Cytogenet Cell Genet., 1997, V. 76, P. 176-178.
  26. Garkavtsev I., Kazarov A., Gudkov A., Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation // Nat. Genet., 1996, V. 14, P. 415-420.
  27. Gill R.L.; Hamel P.A.; Jiang Z.; Zacksenhaus E.; Gallie B.L.; Phillips R.A.: Characterization of the human RB1 promoter and of elements involved in transcriptional regulation.// Cell Growth Differ. 1994. V. 5. P. 467-474.
  28. Gonzalez-Zulueta M., Bender CM., Yang AS., Nguyen T., Beart RW., Van Tornout JM., Jones PA. Methylation of the 5’CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.// Cancer research. 1995. V. 55. P. 4531.
  29. Gorlin R. J., Chaudhry A. P. // New Eng. J. Med. 1960. V. 263. P. 1151-1158.
  30. Gottlieb,T.M., Oren,M. p53 in growth control and neoplasia. // Biochim.Biophys.Acta, 1996, V. 1287, P. 77-102.
  31. Healy E., Rehman I., Angus B., Rees JL. Loss of heterozygosity in sporadic primary cutaneous melanoma.// Genes chromosome cancer. 1995. V. 12. P. 152.
  32. Helbing C.C., Veillette C., Riabowol K., Johnston R.N., Garkavtsev I. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis // Cancer Res., 1997, V. 57, P. 1255-1258.
  33. Herman JG., Merlo A., Mao L., Issa JJ-P., Davidson NE., Sidransky D., Baylin SB. Inactivation of the CDKN2A/p16/MTS1 gene is frequently associated with aberrant DNA mathylation in all common human cancers. // Cancer research. 1995. V. 55. P. 4525.
  34. Hinds,P.W., and Weinberg,R.A. Tumor suppressor genes. // Curr.Opin.Genet., 1994, V. 4, P. 135-141.
  35. Hussain S.P., Harris C.C. // Cancer Res. 1998. V. 58. P. 4023-4037.
  36. Issa J.P., Ottaviano Y.L., Celano P., et al. // Nat. Genet. 1994. V. 7. P. 536-540.
  37. Jager D., Stockert E., Scanlan M.J., Gure A.O., Jager E., Knuth A., Old L.J., Chen Y.T. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene // Cancer Res., 1999, V.59, C.6197-6204.
  38. Jones P., Laird P. Cancer epigenetics comes of age. //Nature Genetics. 1999. V. 21. P. 163-167.
  39. Jones PL et al. Methylated DNA and MeCP2 recruit histone deacetilase to repress transkriptional. // Nature genetics. 1998. V. 19. P. 187-191.
  40. Kamb A., Cell-cycle regulators and cancer.// Trends genetic. 1995. V. 5. P. 136.
  41. Kinzler K.V. and Vogelstein B. Cancer - susceptibility genes. Gatekeepers and caretakers. // Nature. 1997. V. 386. P. 761-763
  42. Kiyono T., Foster S., Koop J. et al. Both pRB/p16 inaktivation and telomerase activity are required to immortalize human epithelial cells. // Nature. 1998. V. 396. P. 84-88.
  43. Koh J., Enders GH., Cynlacht BD., Harlow E. Tumor-derived p16 alleles encoding protein defective in cell-cycle inhibition. // Nature. 1995. V. 375. P. 506.
  44. Lamlum H., Ilyas M., Rowan A., et al. // Nature Med. 1999. V. 5. P. 1071-1075.
  45. Lapidus R.G., Nass S.J., Butash K.A., et al. // Cancer Res. 1998. V. 58. P. 2515-2519.
  46. Lee W. H., Lee E. Y.: The retinoblastoma gene: from its basic umderstanding as a signal mediator for growth fnd differentiation to its use in the treatment qf cancer.// Gan To Kagaku Ryoho. 1997. V. 24. P. 1368-1380.
  47. Levanat S., Gorlin R. J., Fallet S., et al. // Nature Genet. 1996. V. 12. P. 85-87.
  48. Levine A.J., Momand J., Finlay C.A. // Nature. 1991. V.351. P. 453-456.
  49. Li E., Beard C., Jaenisch R. Role for DNA methylation in genetic impinting.// Nature. 1993. V. 366. P. 362-365.
  50. Ludlow J.W.; DeCaprio J.A.; Huang C.-M.; Paycha E.and Livingston D.M.: SV40 Large T antigen binds preferently to an underphosphorylated member of the retinoblastoma susceptibility gene family.// Cell. 1989. V. 56. P. 57-65.
  51. Lukas J., Parry D., Aagaard L., Mann DJ., Bartkova J., Strauss M., Peters G., Bartek J. Retino-blastoma-protein-dependent cell-cycle ingibition by the tumor suppressor p16. // Nature. 1995. V. 375. P. 503.
  52. Macleod Kay Tumor suppressor genes. // Current opinion in genetics and development. 2000. V. 10. P. 81-93.
  53. Mao L., Merlo A., Bedi G., Shapiro GI., Edwards CD., Rollins BJ., Sidranski D. A novel p16/INK4A transcript. //Cancer Research. 1995. V. 55. P. 2995-2997.
  54. McGee T.L.; Yandell D.W. and Druja T.P.: Structure and partial genomic sequence of the human retinoblastoma susceptibility gene.// Gene. 1989. V. 80. P. 119-128.
  55. Munger K.; Werness B.A.; Dyson n.: phelps W.C.; Harlow E. and Howley P.M.: Complex formation of human papillomavirus E7 protein with the retinoblastoma tumor supressor gene product.// EMBO Journal. 1989. V. 8. P. 4099-4105.
  56. Nan X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetilase complex.// Nature. 1998. V. 393. P. 386-389.
  57. Norman E. Sharpless, Ronald A. DePinho. The INK4A/ARF locus and its two products. // Current Opinion in Genetics & Development. 1999. V. 9. P. 22-30.
  58. Ohmori M., Nagai M., Tasaka T., Koeffler H.P., Riabowol K., Takahara J. Decreased expression of p33ING1 mRNA in lymphoid malignancies // Am. J. Hematol., 1999, V. 62, C. 118-119.
  59. Oki E., Maehara Y., Tokunaga E., Kakeji Y., Sugimachi K. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer // Cancer Lett, 1999, V. 147, C. 157-162.
  60. Palmero I., Pantoja C., Serrano M.: p19/ARF links the tumor suppressor p53 to ras. // Nature. 1998. V. 395. P. 125-126.
  61. Peter A. Jones. The DNA methylation paradox.// Trends in Genetics. 1999. V. 15. P. 34-37.
  62. Reeve AE., Sih SA., Raizis AM.,, Feinberg AP. Loss of heterozygosity at a second locus on chromosome 11 in sporadic Wilms’ tumor cells.// Molecular cell biology. 1989. V. 9. P. 1799-1803.
  63. Rosso AA., Tong L., Lee JO., Jeffrey PD., Pavletich NP. Struktural basis for inhibition of the ciklin-dependent kinase Cdk6 by the tumour suppressor p16/INK4A. //Nature. 1998. V. 395. P. 237-243.
  64. S. Perwez Hussain and Curtis C. Harris. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumour suppressor genes. // Cancer Research. 1998. V. 15. P. 4023-4034.
  65. Sambrook, Fritsch, Maniatis. Molecular cloning. // Cold Spring Harbor Laboratory Press. 1989.
  66. Sanchez-Cespedes M., Okami K., Cairns P., Sidransky D. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions // Genes Chromosomes Cancer, 2000, V. 27, C. 319-322.
  67. Sarela AI, Farmery SM, Markham AF, Guillou PJ. The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas. // Eur. J. Cancer, 1999, V. 35, P. 1264-7.
  68. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. // Cell. 1996. V. 85. P. 27.
  69. Sherr CJ., Weber JD. The ARF/p53 pathway. //Current opinion in genetics and development. 2000. V. 10. P. 94-99.
  70. Shinoura N., Muramatsu Y., Nishimura M., Yoshida Y., Saito A., Yokoyama T., Furukawa T., Horii A., Hashimoto M., Asai A., Kirino T., Hamada H. S. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas // Cancer Res., 1999, V. 59, C.5521-5528.
  71. Singer-Sam J and Riggs AD. X chromosome inactivation and DNA methylation. // In Jost JP. and Saluz HP. DNA mathylation: Molecular Biology and Biologycal Signicance. Birkhaeuser Verlag. Basel, Switzerland. PP. 358-354.
  72. Stanbridge,J. Functional evidence for human tumor suppressor genes: chromosome and molecular genetic studies. // Cancer Surv., 1992, V. 12, P. 5-24.
  73. Toyama T., Iwase H., Watson P., Muzik H., Saettler E., Magliocco A., DiFrancesco L., Forsyth P., Garkavtsev I., Kobayashi S., Riabowol K. Suppression of ING1 expression in sporadic breast cancer // Oncogene, 1999, V. 18, C. 5187-5193.
  74. Trapman J., Sleddens HF., van der Weiden MM., Dinjens WN., Konig JJ., Schroder FH., Faber PW., Bosman FT. Loss of heterozygosity of chromosome 8 microsattelite loci implicates a candidate tumor suppressor gene between loci D8S87 and D8S133 in human prostate cancer.// Cancer research. 1994.V. 54. P. 6061.
  75. Vogelstein B. // Nature. 1990. V. 348. P. 681.
  76. Vogelstein B., Kinzler KW. The genetics basis of human cancer. // 1998. USA.
  77. Wallis Y. L., Morton D. G., McKeown C. M., et al. // J. Med. Genet. 1999. V. 36. P. 14-20.
  78. Whyte P.; Buchkovich K. J.; Horowitz J. M.; Friend S. H.; Raybuck M.; Weinberg R. A. and Harlow E.: Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.// Nature. 1988. V. 334. P. 124-129.
  79. Wiggs J.; Nordenskjold M.; Yandell D.; Rapaport J.; Grondin V.; Janson M.; Werelius B.; Petersen R.; Craft A.; Riedel K.; Liberfarb R.; Walton D.; Wilson W. and Dryja T. P.: Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene.// New Eng. J. Med. 1988. V. 318. P. 151-157.
  80. Wong I.H.N., Lo Y.M.D., Zhang J., et al. // Cancer Res. 1999. V. 59. P. 71-73.
  81. Wooster R., Neuhausen S.L., Mangion JQuirck,Y., Ford,D., Collins,N., Nguyen,K., Seal,S., Tran,T., Averill,D. et all. Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. . // Science. 1994. V. 265. P. 2088-2090.
  82. Zeremski M., Hill J.E., Kwek S.S., Grigorian I.A., Gurova K.V., Garkavtsev I.V., Diatchenko L., Koonin E.V., Gudkov A.V. Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. // J. Biol. Chem., 1999, V. 274, P. 32172-81.
  83. Zeremski M., Horrigan S.K., Grigorian I.A., Westbrook C.A., Gudkov A.V. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34 // Somat Cell Mol Genet., 1997, V. 23, P. 233-236.
  84. Zindy F., Eischen CM., Randle DH., Kamijo T., Cleveland JL., Sherr CJ., Roussel MF.: Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalisation. //Genes Dev. 1998. V. 12. P. 2424-2433.

 листать назадоглавлениеОбратная связь



Хостинг от uCoz